2m 2m 2m 2m 2m 2m 2m
RECURSN PHARMA-A (RXRX)
NASDAQ
$3.32+$0.02 (+0.73%)
Price as of Jul 14, 2026 6:08 AM EDT- $1.7BMarket Cap
- -37.50%1-Year Change
- BiotechnologyIndustry
RECURSN PHARMA-A (RXRX)
$3.32+$0.02 (+0.73%)
RXRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.30 | ||
Change | -$0.26 (-7.30%) | ||
Open | $3.52 | ||
High | $3.54 | ||
Low | $3.27 | ||
Previous Close | $3.56 | ||
Volume | 24,497,736 | ||
30-Day Average Volume | 23,629,635 | ||
1-Week Change | -16.67% | ||
1-Month Change | 4.76% | ||
1-Year Change | -37.50% | ||
3-Year Change | -73.46% | ||
5-Year Change | -92.02% | ||
Fundamentals | |||
Shares Outstanding | 524.7M | ||
Total Assets | $1.3B | ||
Market Cap | $1.7B | ||
Enterprise Value | $1.1B | ||
Period: QTR TTM FY | |||
Revenue | $6.3M | ||
Net Income | -$117.5M | ||
Free Cash Flow | -$81.4M | ||
EBIT | -$122.1M | ||
EBITDA | -$102.4M | ||
Net Working Capital | $579.9M | ||
EPS | -$0.22 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | 174 | ||
P/B | 2 | ||
P/E | -15 | ||
PEG | 2 | ||
Price/Free Cash Flow | -21 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue